We thank Sun et al 1 for their comments about our paper entitled "Association of serum osmolarity with contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction." 2 They indicated that in our study only serum osmolarity had a modest predictive accuracy for CIN and emphasized that several biomarkers and related scores for predicting CIN should be considered together for clinical decision-making.
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Although the pathophysiology of CIN is not clearly known, it has a complex and multifactorial nature, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. 3, 4 Patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) constitute the group with the highest risk of developing CIN. 4 Previous studies have demonstrated the impact of many factors such as thrombus burden, delta neutrophil index, platelet to lymphocyte ratio, monocyte to high-density lipoprotein ratio, N-terminal fragment of B-type natriuretic peptide, g-glutamyl transferase levels, red cell distribution width, paraoxonase 1 activity, oxidative stress index, neutrophil to lymphocyte ratio, and high-sensitivity C-reactive protein on CIN development in patients with STEMI undergoing pPCI. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] These studies and our study support the multifactorial pathogenesis of CIN development in patients with STEMI. Serum osmolarity, an easily calculated parameter on admission, may help predict the risk of CIN development in patients with STEMI. Nevertheless, we agree with Sun et al 1 that all these evidence-based parameters should ideally be taken into account when estimating the risk of CIN in patients with STEMI. However, this may make prediction of CIN a very complex process.
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